Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

CPHICHINA PHARMA HOLDINGS, INC.

NYSE · CIK 0001106644
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts430

Identity from submissions API

NameCHINA PHARMA HOLDINGS, INC.
CIK0001106644
TickersCPHI
ExchangesNYSE
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN731564807
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone8689866811730
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • TS ELECTRONICS INC (2003-08-20T04:00:00.000Z → 2006-05-04T04:00:00.000Z)
  • SOFTSTONE INC (2003-02-13T05:00:00.000Z → 2003-08-18T04:00:00.000Z)
  • SOFTSTONE INC /DE/ (2001-08-14T04:00:00.000Z → 2003-01-27T05:00:00.000Z)
  • KILKENNY ACQUISITION CORP (2000-11-13T05:00:00.000Z → 2001-03-30T05:00:00.000Z)
Business address
2ND FLOOR, NO. 17, JINPAN ROAD
HAIKOU
HAINAN PROVINCE
F4
570216
China
Mailing address
2ND FLOOR, NO. 17, JINPAN ROAD
HAIKOU
HAINAN PROVINCE
F4
570216
China

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

429 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-18 10-Q QUARTERLY REPORT 0001213900-26-121812 001-34471 261570491 34 4752227 1 1
2026-11-17 NT 10-Q NOTIFICATION OF LATE FILING 0001213900-26-121329 001-34471 261565524 34 22631
2026-11-10 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-26-118012 001-34471 261540271 34 2630010
2026-10-30 PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-26-114445 001-34471 261508601 34 213143
2026-08-14 10-Q QUARTERLY REPORT 0001213900-26-090173 001-34471 261282680 34 4666110 1 1
2026-07-23 424B5 PROSPECTUS SUPPLEMENT 0001213900-26-080581 333-276481 261195107 33 459051
2026-07-22 8-K CURRENT REPORT 1.01,8.01,9.01 0001213900-26-080475 001-34471 261194565 34 669705 1 1
2026-05-15 10-Q QUARTERLY REPORT 0001213900-26-057705 001-34471 26987093 34 4112384 1 1
2026-04-01 10-K ANNUAL REPORT 0001213900-26-038521 001-34471 26828362 34 6704830 1 1
2026-04-01 NT 10-K NOTIFICATION OF LATE FILING 0001213900-26-038495 001-34471 26828091 34 23453
2026-03-03 8-K CURRENT REPORT 1.01,3.02,9.01 0001213900-26-023022 001-34471 26713916 34 238086 1 1
2026-02-10 8-K CURRENT REPORT 1.01,3.02,9.01 0001213900-26-014338 001-34471 26616801 34 224983 1 1
2026-01-06 8-K CURRENT REPORT 5.07 0001213900-26-001785 001-34471 26511438 34 200859 1 1
2025-12-23 8-K FORM 8-K 1.01,3.02 0001213900-25-125299 001-34471 251600535 34 192596 1 1
2025-12-10 8-K CURRENT REPORT 1.01,3.02 0001213900-25-120129 001-34471 251562532 34 194337 1 1
2025-11-14 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-25-110882 001-34471 251486770 34 1820035
2025-11-12 10-Q QUARTERLY REPORT 0001213900-25-109203 001-34471 251472777 34 4163570 1 1
2025-11-04 PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-25-106092 001-34471 251448913 34 218770
2025-08-14 10-Q QUARTERLY REPORT 0001213900-25-076642 001-34471 251218857 34 4147932 1 1
2025-05-14 10-Q QUARTERLY REPORT 0001213900-25-043334 001-34471 25946014 34 4122531 1 1
2025-04-04 8-K CURRENT REPORT 7.01,9.01 0001213900-25-029000 001-34471 25813960 34 211101 1 1
2025-03-31 10-K ANNUAL REPORT 0001213900-25-026280 001-34471 25793571 34 6216106 1 1
2024-12-26 8-K CURRENT REPORT 1.02 0001213900-24-112685 001-34471 241581373 34 198519 1 1
2024-12-26 8-K CURRENT REPORT 5.07 0001213900-24-112658 001-34471 241581071 34 215365 1 1
2024-12-13 8-K CURRENT REPORT 1.01,9.01 0001213900-24-108617 001-34471 241546875 34 366323 1 1
2024-12-13 424B5 PROSPECTUS SUPPLEMENT 0001213900-24-108616 333-276481 241546867 33 395466
2024-11-13 10-Q QUARTERLY REPORT 0001213900-24-097461 001-34471 241454083 34 4521847 1 1
2024-11-12 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-24-096780 001-34471 241447958 34 2810981
2024-11-01 PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-24-093490 001-34471 241419074 34 230955
2024-08-14 10-Q QUARTERLY REPORT 0001213900-24-068984 001-34471 241207478 34 4369170 1 1
2024-05-30 8-K CURRENT REPORT 1.01,9.01 0001213900-24-047965 001-34471 241005164 34 228987 1 1
2024-05-15 10-Q QUARTERLY REPORT 0001213900-24-043591 001-34471 24950434 34 4033295 1 1
2024-05-08 8-K FORM 8-K 4.01 0001213900-24-040851 001-34471 24925823 34 203646 1 1
2024-04-01 10-K ANNUAL REPORT 0001213900-24-028731 001-34471 24809157 34 10639976 1 1
2024-03-29 8-K FORM 8-K 8.01 0001213900-24-027972 001-34471 24804143 34 197625 1 1
2024-02-23 8-K CURRENT REPORT 7.01,9.01 0001213900-24-016507 001-34471 24671137 34 208663 1 1
2024-02-14 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-02-14 16:00:00 9999999995-24-000463 333-276481 24641885 33 2081
2024-02-14 CORRESP filename1.htm 0001213900-24-013602 8414
2024-02-08 8-K CURRENT REPORT 1.01,3.02 0001213900-24-011587 001-34471 24608975 34 203210 1 1
2024-02-06 CORRESP filename1.htm 0001213900-24-010564 13825
2024-02-06 S-3/A AMENDMENT NO. 1 TO FORM S-3 0001213900-24-010555 333-276481 24600481 33 566626
2024-01-26 SC 13G SCHEDULE 13G 0001213900-24-007039 005-80735 24568797 34 51882
2024-01-26 3 xslF345X02/ownership.xml 0001213900-24-007038 3914
2024-01-25 UPLOAD filename1.pdf 0000000000-24-001007 333-276481 45815
2024-01-12 S-3 REGISTRATION STATEMENT 0001213900-24-003333 333-276481 24532092 33 512342
2024-01-12 SC 13G/A NONE 0001567619-24-000010 005-80735 24531744 34 99621
2023-12-21 8-K CURRENT REPORT 1.01,3.02 0001213900-23-097680 001-34471 231505328 34 200716 1 1
2023-12-19 8-K CURRENT REPORT 5.07,8.01 0001213900-23-096920 001-34471 231497286 34 210478 1 1
2023-11-16 UPLOAD filename1.pdf 0000000000-23-012600 40037
2023-11-13 10-Q QUARTERLY REPORT 0001213900-23-086100 001-34471 231398618 34 4534305 1 1
2023-11-09 CORRESP filename1.htm 0001213900-23-085404 18943
2023-11-07 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-23-084279 001-34471 231383644 34 2495949
2023-10-27 PRE 14A PRELIMINARY PROXY STATEMENT 0001013762-23-007280 001-34471 231355549 34 224957
2023-10-27 UPLOAD filename1.pdf 0000000000-23-011807 44153
2023-10-19 4 xslF345X05/ownership.xml 0001013762-23-005114 5462
2023-10-18 CORRESP filename1.htm 0001013762-23-004725 32950
2023-10-03 8-K CURRENT REPORT 3.01 0001013762-23-001101 001-34471 231303484 34 199334 1 1
2023-09-26 UPLOAD filename1.pdf 0000000000-23-010596 51535
2023-09-08 CORRESP filename1.htm 0001213900-23-075543 1095218
2023-08-14 10-Q QUARTERLY REPORT 0001213900-23-066936 001-34471 231169253 34 3730604 1 1
2023-07-25 UPLOAD filename1.pdf 0000000000-23-007961 59360
2023-05-12 10-Q QUARTERLY REPORT 0001213900-23-039007 001-34471 23915630 34 3648486 1 1
2023-04-20 8-K CURRENT REPORT 1.01,9.01 0001213900-23-031309 001-34471 23833125 34 230648 1 1
2023-03-30 10-K ANNUAL REPORT 0001213900-23-024710 001-34471 23781449 34 7297652 1 1
2023-03-29 8-K CURRENT REPORT 8.01 0001213900-23-024081 001-34471 23775232 34 202417 1 1
2023-03-09 SC 13G SCHEDULE 13G 0001213900-23-018879 005-80735 23719746 34 50049
2023-03-09 3 xslF345X02/ownership.xml 0001213900-23-018875 3932
2023-02-24 8-K CURRENT REPORT 7.01,9.01 0001213900-23-014316 001-34471 23667013 34 210933 1 1
2022-12-30 8-K CURRENT REPORT 5.07 0001213900-22-084016 001-34471 221502020 34 209700 1 1
2022-12-05 SC 13G/A NONE 0001567619-22-021265 005-80735 221444703 34 99543
2022-12-02 8-K CURRENT REPORT 1.01,3.02,9.01 0001213900-22-077369 001-34471 221442832 34 243755 1 1
2022-12-02 8-K CURRENT REPORT 3.01,9.01 0001213900-22-077304 001-34471 221442039 34 228695 1 1
2022-11-14 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-22-072361 001-34471 221387124 34 485883
2022-11-14 10-Q QUARTERLY REPORT 0001213900-22-072200 001-34471 221385246 34 3636366 1 1
2022-11-04 PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-22-069418 001-34471 221362756 34 414081
2022-10-24 S-8 REGISTRATION STATEMENT 0001213900-22-065840 333-267989 221326246 33 189142
2022-09-30 8-K CURRENT REPORT 3.01,9.01 0001213900-22-060675 001-34471 221284212 34 220007 1 1
2022-09-27 SC 13G NONE 0001567619-22-017840 005-80735 221270881 34 99546
2022-08-11 10-Q QUARTERLY REPORT 0001213900-22-046859 001-34471 221155664 34 3477590 1 1
2022-06-22 8-K CURRENT REPORT 3.01,9.01 0001213900-22-034328 001-34471 221032056 34 220468 1 1
2022-05-12 10-Q QUARTERLY REPORT 0001213900-22-025938 001-34471 22917788 34 3278379 1 1
2022-03-30 10-K ANNUAL REPORT 0001213900-22-016151 001-34471 22786455 34 4904614 1 1
2021-12-29 8-K CURRENT REPORT 5.07 0001213900-21-067912 001-34471 211528810 34 204502 1 1
2021-12-16 424B5 PROSPECTUS SUPPLEMENT 0001213900-21-065682 333-251973 211497856 33 364327
2021-11-29 D xslFormDX01/primary_doc.xml 06b 0001213900-21-062343 021-422728 211456110 33 9325
2021-11-23 8-K CURRENT REPORT 1.01,2.03,9.01 0001213900-21-061610 001-34471 211438914 34 485222 1 1
2021-11-15 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-21-059539 001-34471 211412418 34 130947
2021-11-15 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-21-059533 001-34471 211412361 34 195976
2021-11-12 10-Q QUARTERLY REPORT 0001213900-21-058670 001-34471 211403406 34 3552164 1 1
2021-09-15 8-K CURRENT REPORT 5.02,9.01 0001213900-21-048212 001-34471 211255467 34 227851 1 1
2021-09-13 4 xslF345X03/ownership.xml 0001213900-21-047830 5279
2021-08-13 10-Q QUARTERLY REPORT 0001213900-21-042474 001-34471 211172093 34 3593958 1 1
2021-05-14 10-Q QUARTERLY REPORT 0001213900-21-026413 001-34471 21924628 34 2333627 1
2021-03-26 10-K ANNUAL REPORT 0001213900-21-017981 001-34471 21777327 34 3793993 1
2021-01-21 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-01-21 16:00:00 9999999995-21-000225 333-251973 21543658 33 2032
2021-01-19 CORRESP filename1.htm 0001213900-21-002702 7827
2021-01-15 UPLOAD filename1.pdf 0000000000-21-000525 40556
2021-01-08 S-3 REGISTRATION STATEMENT 0001213900-21-001190 333-251973 21517723 33 592722
2021-01-08 4 OWNERSHIP DOCUMENT 0001213900-21-001170 5304
2020-12-29 8-K CURRENT REPORT 5.02,5.07 0001213900-20-045181 001-34471 201422457 34 21482
2020-12-21 S-8 REGISTRATION STATEMENT 0001213900-20-043823 333-251545 201404693 33 121072
2020-11-16 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-20-037362 001-34471 201316949 34 98018
2020-11-16 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-20-037345 001-34471 201316788 34 143638
2020-11-13 10-Q QUARTERLY REPORT 0001213900-20-036919 001-34471 201311461 34 2933597 1
2020-08-13 10-Q QUARTERLY REPORT 0001213900-20-021867 001-34471 201099355 34 2439498 1
2020-05-14 10-Q QUARTERLY REPORT 0001213900-20-012258 001-34471 20877770 34 2343941 1
2020-03-30 10-K ANNUAL REPORT 0001213900-20-008020 001-34471 20757755 34 3667166 1
2019-12-23 8-K CURRENT REPORT 5.07 0001213900-19-026825 001-34471 191306001 34 22985
2019-11-14 10-Q QUARTERLY REPORT 0001213900-19-023467 001-34471 191220004 34 2406885 1
2019-11-06 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-19-022243 001-34471 191197381 34 91690
2019-11-06 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-19-022241 001-34471 191197366 34 215795
2019-08-14 10-Q QUARTERLY REPORT 0001213900-19-015792 001-34471 191026279 34 2585239 1
2019-05-14 10-Q QUARTERLY REPORT 0001213900-19-008566 001-34471 19822850 34 2287465 1
2019-03-28 10-K ANNUAL REPORT 0001213900-19-005094 001-34471 19711929 34 3043774 1
2018-12-06 8-K CURRENT REPORT 5.07 0001213900-18-017006 001-34471 181220699 34 19238
2018-11-14 10-Q QUARTERLY REPORT 0001213900-18-015783 001-34471 181183722 34 2073701 1
2018-10-25 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-18-014461 001-34471 181138616 34 120532
2018-10-25 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-18-014459 001-34471 181138582 34 292945
2018-08-14 10-Q QUARTERLY REPORT 0001213900-18-010992 001-34471 181017226 34 2098549 1
2018-05-14 10-Q QUARTERLY REPORT 0001213900-18-006100 001-34471 18830509 34 1955074 1
2018-04-02 10-K ANNUAL REPORT 0001213900-18-003895 001-34471 18729731 34 3027915 1
2018-03-12 8-K CURRENT REPORT 8.01 0001213900-18-002824 001-34471 18683418 34 24178
2017-12-18 8-K CURRENT REPORT 5.07 0001213900-17-013370 001-34471 171261425 34 25883
2017-11-14 10-Q QUARTERLY REPORT 0001213900-17-012067 001-34471 171201277 34 2244355 1
2017-11-03 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-17-011354 001-34471 171177314 34 129303
2017-11-03 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-17-011352 001-34471 171177274 34 242737
2017-09-12 8-K CURRENT REPORT 3.01,9.01 0001213900-17-009599 001-34471 171081209 34 25123
2017-08-14 10-Q QUARTERLY REPORT 0001213900-17-008653 001-34471 171030195 34 2317867 1
2017-05-11 10-Q cphi10q033117.htm 0001010549-17-000167 001-34471 17835258 34 2200535 1
2017-03-31 10-K cphi10k123116.htm 0001010549-17-000112 001-34471 17730661 34 3040498 1
2017-03-31 8-K cphi8k033017.htm 2.02,9.01 0001213900-17-003047 001-34471 17727821 34 155386
2016-12-28 8-K cphi8k122716.htm 8.01 0001010549-16-000877 001-34471 162072677 34 16009
2016-12-13 8-K cphi8k121316.htm 5.07 0001010549-16-000864 001-34471 162048978 34 36661
2016-12-02 8-K cphi8k120116.htm 4.01,9.01 0001010549-16-000834 001-34471 162031268 34 151751
2016-11-14 10-Q cphi10q093016.htm 0001010549-16-000787 001-34471 161994843 34 3078630 1
2016-10-28 DEFA14A cphidefa14a102816.htm 0001010549-16-000757 001-34471 161958538 34 975046
2016-10-28 DEF 14A cphi14a102816.htm 0001010549-16-000755 001-34471 161958516 34 249458
2016-08-11 10-Q cphi10q063016.htm 0001010549-16-000678 001-34471 161824927 34 3149768 1
2016-05-16 10-Q cphi10q033116.htm 0001010549-16-000606 001-34471 161654538 34 2628188 1
2016-03-30 10-K cphi10k123115.htm 0001010549-16-000541 001-34471 161539752 34 13614351 1
2015-12-28 10-Q/A CHINA PHARMA 0001010549-15-000422 001-34471 151307957 34 3827374 1
2015-12-28 10-Q/A CHINA PHARMA 0001010549-15-000420 001-34471 151307955 34 3769936 1
2015-12-28 10-Q/A CHINA PHARMA 0001010549-15-000418 001-34471 151307953 34 3367078 1
2015-12-28 10-K/A CHINA PHARMA 0001010549-15-000416 001-34471 151307948 34 5321458 1
2015-12-11 8-K CHINA PHARMA 4.02,9.01 0001010549-15-000389 001-34471 151283322 34 35437
2015-12-10 8-K CHINA PHARMA 5.07 0001010549-15-000387 001-34471 151280929 34 41293
2015-11-16 10-Q CHINA PHARMA 0001010549-15-000343 001-34471 151234508 34 3156330 1
2015-10-29 DEFA14A CHINA PHARMA 0001010549-15-000314 001-34471 151181229 34 420397
2015-10-29 DEF 14A CHINA PHARMA 0001010549-15-000313 001-34471 151181227 34 278321
2015-08-14 10-Q CHINA PHARMA 0001010549-15-000256 001-34471 151052863 34 3073037 1
2015-05-11 10-Q CHINA PHARMA 0001010549-15-000168 001-34471 15850685 34 3703898 1
2015-03-30 10-K CHINA PHARMA 0001010549-15-000090 001-34471 15734474 34 6032305 1
2014-12-31 8-K CHINA PHARMA 5.07 0001010549-14-000673 001-34471 141318354 34 23376
2014-11-21 DEFA14C CHINA PHARMA HOLDINGS 0001010549-14-000635 001-34471 141240123 34 465597
2014-11-20 DEF 14A CHINA PHARMA HOLDINGS 0001010549-14-000633 001-34471 141240114 34 256343
2014-11-14 10-Q CHINA PHARMA HOLDINGS 0001010549-14-000619 001-34471 141224046 34 3994625 1
2014-08-14 10-Q CHINA PHARMA HOLDINGS 0001010549-14-000422 001-34471 141042690 34 2930283 1
2014-05-15 10-Q CHINA PHARMA HOLDINGS 0001010549-14-000242 001-34471 14844203 34 3587264 1
2014-03-20 10-K CHINA PHARMA HOLDINGS, INC. 0001010549-14-000114 001-34471 14706884 34 6623324 1
2013-12-17 8-K CHINA PHARMA HOLDINGS 5.07 0001010549-13-000745 001-34471 131282025 34 24365
2013-11-14 10-Q CHINA PHARMA HOLDINGS 0001010549-13-000676 001-34471 131220532 34 4359532 1
2013-11-06 DEFA14A CHINA PHARMA HOLDINGS 0001010549-13-000626 001-34471 131196860 34 367661
2013-11-06 DEF 14A CHINA PHARMA HOLDINGS, INC. 0001010549-13-000624 001-34471 131196841 34 302865
2013-10-15 8-K CHINA PHARMA HOLDINGS, INC. 4.01 0001010549-13-000594 001-34471 131150552 34 22795
2013-09-04 8-K CHINA PHARMA HOLDINGS, INC. 4.01,9.01 0001010549-13-000560 001-34471 131078072 34 52620
2013-08-14 10-Q CHINA PHARMA HOLDINGS, INC. 0001010549-13-000521 001-34471 131039288 34 5450365 1
2013-05-14 10-Q CHINA PHARMA HOLDINGS 0001010549-13-000329 001-34471 13842049 34 3107517 1
2013-03-14 10-K CHINA PHARMA HOLDINGS, INC. 0001010549-13-000144 001-34471 13690862 34 5599959 1
2013-02-14 SC 13G cphi13g021513.txt 0001166134-13-000006 005-80735 13604946 34 17111
2013-02-12 SC 13G/A d1345452_13g-a.htm 0000919574-13-000765 005-80735 13596401 34 231454
2013-01-04 8-K CHINA PHARMA HOLDINGS, INC. 1.01,3.03,9.01 0001010549-13-000005 001-34471 13512148 34 273975
2012-12-26 8-K CHINA PHARMA HOLDINGS, INC. 5.07 0001010549-12-001324 001-34471 121285396 34 31483
2012-11-19 DEF 14A CHINA PHARMA HOLDINGS, INC. 0001010549-12-001246 001-34471 121214616 34 516270
2012-11-14 10-Q CHINA PHARMA HOLDINGS, INC. 0001010549-12-001213 001-34471 121204466 34 4070468 1
2012-11-09 PRE 14A CHINA PHARMA HOLDINGS, INC. 0001010549-12-001175 001-34471 121193508 34 516130
2012-08-14 10-Q CHINA PHARMA HOLDINGS, INC 0001010549-12-000896 001-34471 121032847 34 4054175 1
2012-05-14 10-Q CHINA PHARMA HOLDINGS, INC 0001010549-12-000533 001-34471 12839704 34 2024032 1
2012-05-01 4 OWNERSHIP DOCUMENT 0001010549-12-000445 11744
2012-04-30 8-K CHINA PHARMA HOLDINGS, INC. 5.02,9.01 0001010549-12-000438 001-34471 12795511 34 60343
2012-03-14 10-K CHINA PHARMA HOLDINGS, INC. 0001010549-12-000255 001-34471 12691062 34 4038282 1
2012-03-07 UPLOAD filename1.pdf 0000000000-12-011860 48355
2012-03-06 10-Q/A CHINA PHARMA HOLDINGS, INC. 0001010549-12-000234 001-34471 12671546 34 2831247 1
2012-03-06 CORRESP filename1.htm 0001010549-12-000232 42061
2012-03-02 8-K CHINA PHARMA HOLDINGS, INC. 4.02 0001010549-12-000215 001-34471 12663313 34 26666
2012-02-28 CORRESP filename1.htm 0001010549-12-000205 166229
2012-02-15 SC 13G cphi13g021512.txt 0001166134-12-000005 005-80735 12613466 34 16925
2012-02-14 SC 13G/A d1266273_13g-a.htm 0000919574-12-001550 005-80735 12607841 34 202103
2012-02-13 CORRESP filename1.htm 0001010549-12-000139 74642
2012-02-10 SC 13G/A cphi_2.txt 0000937394-12-000076 005-80735 12592546 34 10432
2012-02-10 SC 13G/A cphi_1.txt 0000937394-12-000016 005-80735 12590645 34 11331
2012-01-17 CORRESP filename1.htm 0001010549-12-000055 97265
2011-12-30 8-K g5686.htm 5.07 0001165527-11-001254 001-34471 111288259 34 32519
2011-12-29 CORRESP filename1.htm 0001165527-11-001248 13255
2011-12-16 UPLOAD filename1.pdf 0000000000-11-072147 67637
2011-11-23 DEFA14A CHINA PHARMA HOLDINGS, INC. 0001010549-11-001316 001-34471 111224318 34 609040
2011-11-17 CORRESP filename1.htm 0001010549-11-001305 66626
2011-11-14 DEF 14A CHINA PHARMA HOLDINGS, INC. 0001010549-11-001258 001-34471 111198176 34 307012
2011-11-10 10-Q CHINA PHARMA HOLDINGS, INC. 0001010549-11-001255 001-34471 111195745 34 2472909 1
2011-11-02 UPLOAD filename1.pdf 0000000000-11-063928 60693
2011-10-24 CORRESP filename1.htm 0001010549-11-001170 55878
2011-09-23 CORRESP filename1.htm 0001010549-11-001081 13547
2011-09-13 UPLOAD filename1.pdf 0000000000-11-054533 61237
2011-09-06 10-Q/A CHINA PHARMA HOLDINGS, INC. 0001010549-11-000997 001-34471 111076269 34 1778833 1
2011-08-19 CORRESP filename1.htm 0001010549-11-000886 201254
2011-08-16 CORRESP filename1.htm 0001010549-11-000858 12521
2011-08-10 10-Q CHINA PHARMA HOLDINGS, INC. 0001010549-11-000829 001-34471 111025157 34 1036138
2011-08-03 CORRESP filename1.htm 0001010549-11-000788 11525
2011-07-25 UPLOAD filename1.pdf 0000000000-11-044852 69014
2011-06-01 8-K CHINA PHARMA HOLDINGS, INC,. 5.02,9.01 0001010549-11-000554 001-34471 11884656 34 261147
2011-05-27 4 ZHILIN LI 0001010549-11-000528 8264
2011-05-27 4 FRANK WAUNG 0001010549-11-000526 8348
2011-05-10 10-Q CHINA PHARMA HOLDINGS, INC. 0001010549-11-000431 001-34471 11829277 34 571384
2011-03-17 10-K/A CHINA PHARMA HOLDINGS, INC. 0001010549-11-000249 001-34471 11695945 34 1679396
2011-03-15 10-Q/A CHINA PHARMA HOLDINGS, INC. 0001010549-11-000240 001-34471 11689521 34 1117308
2011-03-15 10-Q/A CHINA PHARMA HOLDINGS, INC. 0001010549-11-000238 001-34471 11689509 34 1066290
2011-03-15 10-Q/A CHINA PHARMA HOLDINGS, INC. 0001010549-11-000236 001-34471 11689486 34 844896
2011-03-03 10-K CHINA PHARMA HOLDINGS, INC. 0001010549-11-000201 001-34471 11658335 34 1819575
2011-03-02 4 FORM 4 WUANG 0001010549-11-000198 5322
2011-02-16 SC 13G cphi13g021511.txt 0001166134-11-000013 005-80735 11615585 34 17347
2011-02-11 SC 13G/A d1168707_13g-a.htm 0000919574-11-000820 005-80735 11598789 34 185211
2011-02-10 SC 13G/A cphi_.txt 0000937394-11-000020 005-80735 11589777 34 11750
2010-12-29 8-K CHINA PHARMA HOLDINGS, INC. 5.07 0001010549-10-000840 001-34471 101277357 34 26579
2010-11-19 4 PRIMARY DOCUMENT 0001010549-10-000745 10748
2010-11-12 DEFA14A CHINA PHARMA HOLDINGS, INC. 0001010549-10-000708 001-34471 101187898 34 374249
2010-11-12 DEF 14A CHINA PHARMA HOLDINGS, INC. 0001010549-10-000706 001-34471 101187873 34 625014
2010-11-10 10-Q CHINA PHARMA HOLDINGS, INC. 0001010549-10-000688 001-34471 101180646 34 737738
2010-08-09 10-Q CHINA PHARMA HOLDINGS, INC. 0001010549-10-000470 001-34471 101001743 34 1171884
2010-05-10 10-Q CHINA PHARMA HOLDINGS, INC. 0001010549-10-000294 001-34471 10817495 34 494059
2010-05-05 DEF 14C CHINA PHARMA HOLDINGS, INC. 0001010549-10-000280 001-34471 10802220 34 351268
2010-05-03 UPLOAD filename1.pdf 0000000000-10-024061 12191
2010-04-30 PRER14C CHINA PHARMA HOLDINGS, INC. 0001010549-10-000258 001-34471 10788119 34 431788
2010-04-26 UPLOAD filename1.pdf 0000000000-10-022578 24901
2010-04-22 CORRESP filename1.htm 0001010549-10-000243 139469
2010-04-22 PRER14C CHINA PHARMA HOLDINGS, INC. 0001010549-10-000241 001-34471 10764988 34 324989
2010-04-07 UPLOAD filename1.pdf 0000000000-10-018974 24359
2010-04-01 PRE 14C CHINA PHARMA HOLDINGS, INC. 0001010549-10-000195 001-34471 10722633 34 107873
2010-03-04 10-K cph10k123109.htm 0001010549-10-000119 001-34471 10657537 34 1040147
2010-02-24 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001010549-10-000048,2010-02-24 9999999995-10-000582 333-141734 10631436 33 2457
2010-02-16 SC 13G/A SCHEDULE 13G/A(2) -- CHINA PHARMA HOLDINGS, INC. 0000919574-10-001335 005-80735 10604015 34 189686
2010-02-10 4 xslF345X03/cph4tsui021010_ex.xml 0001010549-10-000082 5038
2010-02-03 POS AM cphposam1020310.htm 0001010549-10-000048 333-141734 10570967 33 326174
2010-01-15 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2010-01-15 12:00:00 9999999995-10-000236 333-164049 10531767 33 2444
2010-01-12 CORRESP filename1.htm 0001010549-10-000018 18663
2010-01-12 CORRESP filename1.htm 0001010549-10-000016 41056
2010-01-07 UPLOAD filename1.pdf 0000000000-10-001317 35449
2009-12-28 S-3 cphs3122209.htm 0001010549-09-000859 333-164049 091262399 33 1450481
2009-11-10 10-Q cph10q093009.htm 0001010549-09-000753 001-34471 091172317 34 343734
2009-10-19 3 xslF345X02/cph3dong101909_ex.xml 0001010549-09-000689 4349
2009-10-16 3 PRIMARY DOCUMENT 0001010549-09-000687 3630
2009-10-16 3 PRIMARY DOCUMENT 0001010549-09-000686 3640
2009-10-15 4 PRIMARY DOCUMENT 0001010549-09-000685 7990
2009-10-01 424B3 cph424b3100109.htm 0001010549-09-000671 333-152272 091097499 33 33837
2009-10-01 8-K cph8k100109.htm 8.01,9.01 0001010549-09-000669 001-34471 091097490 34 28883
2009-09-30 3 xslF345X02/cph3waung093009_ex.xml 0001010549-09-000665 4152
2009-09-29 CERTNYS AUTO-GENERATED PAPER DOCUMENT 9999999997-09-025317 001-34471 09012368 34 2048
2009-09-28 424B3 cph424b3092809.htm 0001010549-09-000663 333-152272 091089483 33 91034
2009-09-28 8-A12B cph812b092809.htm 0001010549-09-000661 001-34471 091089476 34 21160
2009-09-23 DEFR14C cphdef14c092309.htm 0001010549-09-000649 000-29523 091082132 34 223014
2009-09-23 DEF 14C cphdef14c092309.htm 0001010549-09-000646 000-29523 091082096 34 223158
2009-09-15 PRE 14C cphpre14ca091509.htm 0001010549-09-000626 000-29523 091069857 34 246757
2009-09-04 8-K cph8k090409.htm 5.02,9.01 0001010549-09-000622 000-29523 091055098 34 18285
2009-09-03 PRE 14C cphpre14c090309.htm 0001010549-09-000620 000-29523 091052750 34 228573
2009-08-28 8-K cph8k082809.htm 8.01,9.01 0001010549-09-000614 000-29523 091041464 34 71032
2009-08-11 10-Q cph10q063009.htm 0001010549-09-000573 000-29523 091004005 34 299861
2009-07-23 UPLOAD filename1.pdf 0000000000-09-039089 16213
2009-06-30 424B3 cph424b3062909.htm 0001010549-09-000469 333-152272 09918572 33 145130
2009-06-25 DEF 14C cphdef14c062509.htm 0001010549-09-000463 000-29523 09908694 34 72252
2009-06-24 CORRESP filename1.htm 0001010549-09-000461 27517
2009-06-24 10-Q/A cph10qa033109.htm 0001010549-09-000459 000-29523 09907622 34 62619
2009-06-24 10-K/A cph10ka123108.htm 0001010549-09-000457 000-29523 09907611 34 139979
2009-06-24 10-Q/A cph10qa2093008.htm 0001010549-09-000455 000-29523 09907597 34 63626
2009-06-24 10-Q/A cph10qa2063008.htm 0001010549-09-000453 000-29523 09907588 34 63973
2009-06-24 10-Q/A cph10qa2033108.htm 0001010549-09-000451 000-29523 09907581 34 63270
2009-06-24 10-K/A cph10ka123107.htm 0001010549-09-000449 000-29523 09907578 34 120340
2009-06-22 PRE 14C cphpre14c062209.htm 0001010549-09-000445 000-29523 09902568 34 72285
2009-05-14 10-Q cph10q033109.htm 0001010549-09-000361 000-29523 09826751 34 303335
2009-05-04 424B3 cph424b3050409.htm 0001010549-09-000339 333-152272 09791771 33 42370
2009-04-30 8-K cph8k043009.htm 5.02,9.01 0001010549-09-000331 000-29523 09781445 34 32183
2009-03-27 UPLOAD filename1.pdf 0000000000-09-015861 25451
2009-03-23 424B3 cph424b3032309.htm 0001010549-09-000186 333-152272 09698820 33 1197972
2009-03-17 10-K cph10k123108.htm 0001010549-09-000178 000-29523 09688982 34 1181214
2009-03-12 CORRESP filename1.txt 0001010549-09-000166 8950
2009-03-12 10-Q/A cph10qsba093008.txt 0001010549-09-000164 000-29523 09674636 34 20444
2009-03-12 10-Q/A cph10qsba063008.txt 0001010549-09-000162 000-29523 09674632 34 23633
2009-03-12 10-Q/A cph10qsba033108.txt 0001010549-09-000160 000-29523 09674628 34 23271
2009-03-12 10KSB/A cph10ksba123107.txt 0001010549-09-000158 000-29523 09674620 34 35786
2009-02-13 SC 13G/A d962510_13g-a.txt 0000919574-09-002538 005-80735 09600316 34 13348
2008-12-29 8-K cph8k122908.txt 3.02,9.01 0001010549-08-001044 000-29523 081271378 34 72132
2008-12-23 UPLOAD filename1.pdf 0000000000-08-063448 39095
2008-11-06 10-Q cph10q093008.txt 0001010549-08-000871 000-29523 081168020 34 110418
2008-08-14 424B3 cph424b081408.txt 0001010549-08-000688 333-152272 081015650 33 267252
2008-08-12 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2008-08-12 09:00:00 9999999995-08-002542 333-152272 081011385 33 2445
2008-08-07 CORRESP filename1.txt 0001010549-08-000635 3592
2008-08-05 10QSB cph10q063008.txt 0001010549-08-000625 000-29523 08991364 34 111377
2008-08-04 CORRESP filename1.txt 0001010549-08-000619 3938
2008-07-29 S-1/A cphs1a072908.txt 0001010549-08-000605 333-152272 08974824 33 298888
2008-07-15 UPLOAD filename1.pdf 0000000000-08-034899 39413
2008-07-11 DEF 14C cphdef14c071108.txt 0001010549-08-000564 000-29523 08948491 34 33918
2008-07-11 S-1 cphs1071108.txt 0001010549-08-000562 333-152272 08948447 33 316721
2008-07-10 UPLOAD filename1.pdf 0000000000-08-034161 19585
2008-07-10 CORRESP filename1.txt 0001010549-08-000556 27923
2008-07-02 UPLOAD filename1.pdf 0000000000-08-032781 33267
2008-06-27 8-K cph8k062708.txt 3.02,9.01 0001010549-08-000539 000-29523 08921108 34 114082
2008-06-27 PRE 14C cphpre14c062508.txt 0001010549-08-000537 000-29523 08920770 34 73879
2008-06-09 SC 13G d890294_13g.txt 0000919574-08-003630 005-80735 08888608 34 12711
2008-05-28 8-K cphi8k052108.txt 1.01,3.02,7.01,9.01 0001010549-08-000461 000-29523 08863618 34 262049
2008-04-30 10QSB cph10qsb033108.txt 0001010549-08-000323 000-29523 08790370 34 88041
2008-03-31 10KSB cph10ksb123107.txt 0001010549-08-000226 000-29523 08721712 34 237072
2008-02-28 8-K cph8k022508.txt 2.02,8.01,9.01 0001010549-08-000129 000-29523 08648623 34 10611
2008-02-04 8-K cph8k020408.txt 9.01 0001010549-08-000052 000-29523 08570724 34 8606
2007-11-14 10QSB cph10qsb093007.txt 0001010549-07-000941 000-29523 071241007 34 87312
2007-11-13 SC 13D/A cph13dyang111307.txt 0001010549-07-000921 005-80735 071234952 34 13290
2007-11-13 SC 13D/A cph13dmei111307.txt 0001010549-07-000919 005-80735 071234934 34 13657
2007-11-08 4 xslF345X02/cph4tsui110707_ex.xml 0001010549-07-000910 5094
2007-08-13 10QSB chpha10qsb063007.txt 0001010549-07-000644 000-29523 071050152 34 89429
2007-05-15 10QSB cph10qsb033107.txt 0001010549-07-000393 000-29523 07848079 34 74555
2007-05-08 424B3 cph424b3050407.txt 0001010549-07-000372 333-141734 07826450 33 244329
2007-05-04 EFFECT xslEFFECTX01/primary_doc.xml SB-2,,2007-05-04 12:00:00 9999999995-07-001770 333-141734 07822163 33 2445
2007-05-03 CORRESP filename1.txt 0001010549-07-000365 3892
2007-04-24 SB-2/A cphsb2a2033007.txt 0001010549-07-000339 333-141734 07783772 33 267317
2007-04-17 UPLOAD filename1.pdf 0000000000-07-018919 39007
2007-04-03 SB-2/A cphsb2a033007.txt 0001010549-07-000288 333-141734 07742770 33 265894
2007-03-30 SB-2 cphsb2033007.txt 0001010549-07-000271 333-141734 07734609 33 268386
2007-03-28 10KSB cph10ksb123106.txt 0001010549-07-000263 000-29523 07724463 34 250356
2007-02-14 SC 13G/A feb13ga-china_pharma.htm 0000950138-07-000136 005-80735 07617815 34 92632
2007-02-06 8-K cph8k020107.txt 1.01,3.02,7.01,9.01 0001010549-07-000095 000-29523 07582710 34 101372
2006-11-13 10QSB cph10qsb093006.txt 0001010549-06-000742 000-29523 061209591 34 96594
2006-11-08 10KSB/A cphi10ksba123105.txt 0001010549-06-000730 000-29523 061196629 34 191471
2006-09-25 SC 13D/A cphisc13damei091306.txt 0001010549-06-000642 005-80735 061105814 34 17867
2006-09-25 SC 13D cphisc13dli091306.txt 0001010549-06-000641 005-80735 061105773 34 17570
2006-09-21 8-K cph8k090606.txt 2.02,9.01 0001010549-06-000635 000-29523 061102527 34 8011
2006-09-14 4 xslF345X02/cphi4tsui091306_ex.xml 0001010549-06-000620 5226
2006-09-14 4 xslF345X02/cphi4li091306_ex.xml 0001010549-06-000619 5259
2006-08-14 10QSB cph10qsb063006.txt 0001010549-06-000553 000-29523 061027162 34 66759
2006-05-16 4 PRIMARY DOCUMENT 0000899797-06-000189 5195
2006-05-15 10QSB cphi10qsb033106.txt 0001010549-06-000280 000-29523 06837398 34 62678
2006-05-04 8-K FORM 8-K 5.02,9.01 0000899797-06-000167 000-29523 06807034 34 21669
2006-03-31 10KSB ts10ksb123105.txt 0001010549-06-000169 000-29523 06726845 34 186979
2006-03-28 DEF 14C DEFINITIVE INFORMATION STATEMENT 0000899797-06-000106 000-29523 06713535 34 61235
2006-03-16 424B3 RULE 424(B)(3) 0000899797-06-000098 333-129161 06690111 33 707145
2006-03-15 PRER14C SCHEDULE 14C - AMENDMENT NO. 1 0000899797-06-000094 000-29523 06687133 34 60469
2006-03-06 SC 13D SCHEDULE 13D 0000899797-06-000075 005-80735 06666560 34 37222
2006-02-01 CORRESP filename1.htm 0001204459-06-000094 6729
2006-01-25 CORRESP filename1.htm 0001204459-06-000067 8292
2006-01-25 PRE 14C TS ELECTRONICS, INC. - SCHEDULE 14C 0001204459-06-000066 000-29523 06548867 34 38671
2005-12-28 3 xslF345X02/ts3li101905_ex.xml 0001010549-05-000950 4222
2005-12-28 3 xslF345X02/ts3yang101905_ex.xml 0001010549-05-000949 4186
2005-12-28 3 xslF345X02/ts3wu101905_ex.xml 0001010549-05-000948 4208
2005-12-28 3 xslF345X02/ts3tsui101905_ex.xml 0001010549-05-000947 4175
2005-12-23 SB-2/A tssb2a2122205.txt 0001010549-05-000945 333-129161 051284701 33 423457
2005-11-18 10QSB ts10qsb093005.txt 0001010549-05-000854 000-29523 051214640 34 74955
2005-11-16 SB-2/A tssb2a111405.txt 0001010549-05-000846 333-129161 051209587 33 353050
2005-11-14 NT 10-Q ts12b2510q093005.txt 0001010549-05-000824 000-29523 051199106 34 8348
2005-10-27 SC 13G SCHEDULE 13G 0000950134-05-019859 005-80735 051159638 34 55546
2005-10-26 UPLOAD filename1.txt 0000000000-05-054555 5671
2005-10-20 SB-2 tssb2101705.txt 0001010549-05-000757 333-129161 051147981 33 390987
2005-10-20 8-K ts8k101905.txt 1.01,2.01,3.02,5.01 0001010549-05-000756 000-29523 051147972 34 402021
2005-10-04 3 xslF345X02/ts3hfilp100405_ex.xml 0001010549-05-000706 4220
2005-10-04 3 xslF345X02/ts3brigante100405_ex.xml 0001010549-05-000705 4585
2005-10-04 3 xslF345X02/ts3diamond100405_ex.xml 0001010549-05-000704 4559
2005-10-04 3 xslF345X02/ts3rosenberg100405_ex.xml 0001010549-05-000703 4500
2005-10-04 3 xslF345X02/ts3halter100405_ex.xml 0001010549-05-000702 4526
2005-10-04 3 xslF345X02/hfillc3100405_ex.xml 0001010549-05-000701 4527
2005-10-04 4 xslF345X02/ts4halter100405_ex.xml 0001010549-05-000699 7143
2005-10-04 SC 13D tssc13dhalter100405.txt 0001010549-05-000698 005-80735 051122323 34 42165
2005-09-23 10KSB ts10ksb063005.txt 0001010549-05-000661 000-29523 051100802 34 102178
2005-08-23 CORRESP filename1.txt 0001010549-05-000599 5061
2005-08-19 UPLOAD filename1.txt 0000000000-05-042952 5584
2005-08-18 8-K ts8k081705.txt 4.01,9.01 0001010549-05-000587 000-29523 051035329 34 7173
2005-05-11 SC 13D tssc13dhalter051105.txt 0001010549-05-000311 005-80735 05821633 34 45545
2005-05-11 3 xslF345X02/ts3halter051105_ex.xml 0001010549-05-000310 4427
2005-05-11 8-K ts8k051105.txt 3.02,5.01,5.02,9.01 0001010549-05-000309 000-29523 05821582 34 35395
2005-05-09 10QSB tselectronic_10q-033105.txt 0001019687-05-001291 000-29523 05812972 34 56197
2005-03-29 8-K tselectronics_8k-011405.txt 1.02,8.01 0001019687-05-000832 000-29523 05708870 34 6074
2005-02-22 10QSB tselectronics_10q-123104.txt 0001019687-05-000497 000-29523 05632188 34 58848
2005-02-14 NT 10-Q ts_ext.txt 0001019687-05-000386 000-29523 05606231 34 8206
2004-11-24 10QSB tselect_10q-093004.txt 0001019687-04-002657 000-29523 041167037 34 58663
2004-11-15 NT 10-Q TS ELECTRONICS NT-10Q 9-30-04 0001060830-04-000381 000-29523 041143613 34 27564
2004-11-15 NTN 10Q TS ELECTRONICS, INC. NT-10Q 9-30-04 0001060830-04-000378 000-29523 041143493 34 27576
2004-10-14 10KSB TS ELECTRONICS 10KSB 6-30-04 0001060830-04-000339 000-29523 041077697 34 802782
2004-10-04 8-K/A TS ELECTRONICS 8K AMD 1 8-17-04 1.01 0001060830-04-000333 000-29523 041062792 306321
2004-09-27 NT 10-K TS ELECTRONICS, INC. NT 10K 6-30-04 0001060830-04-000329 000-29523 041047858 28358
2004-08-20 8-K TS ELECTRONICS 8K 8-17-04 1,2,7 0001060830-04-000308 000-29523 04989384 197819
2004-05-17 10QSB tselectronics10qsb33104.txt 0001060830-04-000148 000-29523 04812874 50209
2004-03-25 10KSB/A tselectronics10ksbamd2.txt 0001060830-04-000065 000-29523 04690383 140906
2004-03-09 8-K/A tselectronics8kamd1.txt 4,7 0001060830-04-000060 000-29523 04655672 13205
2004-02-18 10QSB tselectronics10qsb123103.txt 0001060830-04-000045 000-29523 04613178 50486
2004-02-17 NT 10-Q tselectronics123103ext.txt 0001060830-04-000032 000-29523 04606170 7763
2004-02-06 8-K tselectronics8k2404.txt 4 0001060830-04-000022 000-29523 04572342 7655
2004-01-20 AW tselectronicsawsch13c.txt 0001060830-04-000016 000-29523 04532415 3460
2003-12-08 10KSB/A tselectronics10ksbamd1.txt 0001060830-03-000265 000-29523 031041736 131985
2003-12-08 PRER14C tselectronicspre14camd2.txt 0001060830-03-000262 000-29523 031041706 257357
2003-11-19 10QSB tselectronics10qsb93003.txt 0001060830-03-000255 000-29523 031013709 132470
2003-11-17 NT 10-Q tselectronics093003ext.txt 0001060830-03-000234 000-29523 031007124 7765
2003-10-14 10KSB tselectronics10ksb63003.txt 0001060830-03-000205 000-29523 03939667 122905
2003-10-10 PRER14C tselectronicssch14camd1.txt 0001060830-03-000204 000-29523 03936574 224587
2003-10-09 PRE 14C tselectronicssch14camd1.txt 0001060830-03-000203 000-29523 03935714 224624
2003-09-25 NT 10-K tselectronics63003.txt 0001060830-03-000199 000-29523 03909450 7750
2003-08-29 10KSB/A tselectronics10ksbamd3.txt 0001060830-03-000188 000-29523 03872851 132631
2003-08-20 PRE 14C tselectronic14c.txt 0001060830-03-000176 000-29523 03858388 198963

Latest XBRL company facts

One latest value per concept from companyfacts (430 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 43.02M 2026-11-11 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
dei EntityPublicFloat Entity Public Float USD 4.29M 2025-06-30 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap AccountsAndOtherReceivablesNetCurrent Accounts and Other Receivables, Net, Current USD 275,244 2023-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-066936
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 1.61M 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-068984
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 5.85M 2012-03-31 2012 Q1 10-Q 2012-05-14 0001010549-12-000533
us-gaap AccountsPayableOtherCurrent Accounts Payable, Other, Current USD 2.57M 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap AccountsPayableOtherCurrentAndNoncurrent Accounts Payable, Other USD 375,351 2023-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-066936
us-gaap AccountsPayableTradeCurrent Accounts Payable, Trade, Current USD 304,494 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap AccountsReceivableGrossCurrent Accounts Receivable, before Allowance for Credit Loss, Current USD 216,414 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap AccountsReceivableNet Accounts Receivable, after Allowance for Credit Loss USD 11.35M 2015-06-30 2015 Q2 10-Q 2015-12-28 0001010549-15-000420
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 196,588 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD -24,259 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-066936
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 236,359 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap AccruedSalariesCurrent Accrued Salaries, Current USD 1.26M 2024-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097461
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 35.38M 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 13.04M 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 77.88M 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap AdjustmentForAmortization Amortization USD 851,611 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 36,270 2022-01-01 2022-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028731
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 116,993 2010-01-01 2010-12-31 2011 FY 10-K 2012-03-14 0001010549-12-000255
us-gaap AdvancesOnInventoryPurchases Advances on Inventory Purchases USD 43.14M 2015-06-30 2015 Q2 10-Q 2015-12-28 0001010549-15-000420
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097461
us-gaap AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables Allowance for Doubtful Accounts, Premiums and Other Receivables USD 19,826 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 10,000 2025-12-31 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 19,826 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap AllowanceForDoubtfulAccountsReceivableWriteOffs Accounts Receivable, Allowance for Credit Loss, Writeoff USD 2.67M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026280
us-gaap AllowanceForDoubtfulOtherReceivablesCurrent Allowance for Doubtful Other Receivables, Current USD 27,978 2021-03-31 2021 Q1 10-Q 2021-05-14 0001213900-21-026413
us-gaap AllowanceForNotesAndLoansReceivableCurrent Financing Receivable, Allowance for Credit Loss, Current USD 39,806 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 2.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 13,300 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-14 0001213900-25-043334
us-gaap AssetAcquisitionConsiderationTransferredOtherAssets AssetAcquisitionConsiderationTransferredOtherAssets USD 65,639 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-066936
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 17.02M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-26 0001213900-21-017981
us-gaap Assets Assets USD 46.93M 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap AssetsCurrent Assets, Current USD 5.39M 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 1,825 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-090173
us-gaap AssetsHeldInTrustCurrent Assets Held-in-trust, Current USD 1,825 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-090173
us-gaap BankAcceptancesExecutedAndOutstanding Bank Acceptances Executed and Outstanding USD 109,908 2019-12-31 2020 FY 10-K 2021-03-26 0001213900-21-017981
us-gaap BuildingsAndImprovementsGross Buildings and Improvements, Gross USD 9.05M 2023-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-066936
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 143,151 2011-01-01 2011-12-31 2011 FY 10-K 2012-03-14 0001010549-12-000255
us-gaap CapitalLeaseObligations Capital Lease Obligations USD 236,055 2018-12-31 2019 Q1 10-Q 2019-05-14 0001213900-19-008566
us-gaap Cash Cash USD 1.18M 2021-09-09 2023 FY 10-K 2024-04-01 0001213900-24-028731
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 3.68M 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -424,981 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-14 0001213900-19-023467
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 3.68M 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 3.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 458,233 2014-12-31 2014 FY 10-K 2015-12-28 0001010549-15-000416
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 10,000 2022-12-27 2025 Q3 10-Q 2025-11-12 0001213900-25-109203
us-gaap CommonStockDividendsShares Common Stock Dividends, Shares shares 3.00M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097461
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 43.02M 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 43.02M 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap CommonStocksIncludingAdditionalPaidInCapital Common Stocks, Including Additional Paid in Capital USD 90,000 2022-10-03 2022 FY 10-K 2023-03-30 0001213900-23-024710
us-gaap CommonStockValue Common Stock, Value, Issued USD 43,022 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap CommonUnitIssued Common Unit, Issued shares 18,000 2022-10-03 2023 FY 10-K 2024-04-01 0001213900-24-028731
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -3.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap ConstructionInProgressGross Construction in Progress, Gross USD 0 2015-12-31 2015 FY 10-K 2016-03-30 0001010549-16-000541
us-gaap ConstructionLoan Construction Loan CNY 3.80M 2022-12-30 2023 Q2 10-Q 2023-08-14 0001213900-23-066936
us-gaap ConstructionLoanNoncurrent Long-term Construction Loan, Noncurrent USD 2.15M 2019-12-31 2020 FY 10-K 2021-03-26 0001213900-21-017981
us-gaap ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent Contract with Customer, Asset, Allowance for Credit Loss, Current USD 4,029 2025-12-31 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 48,264 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 1.85M 2023-01-01 2023-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097461
us-gaap ConversionOfStockSharesIssued1 Conversion of Stock, Shares Issued shares 3.00M 2023-12-15 2023 FY 10-K 2024-04-01 0001213900-24-028731
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 5.25M 2021-12-31 2022 FY 10-K 2023-03-30 0001213900-23-024710
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 5.25M 2021-11-17 2022 FY 10-K 2023-03-30 0001213900-23-024710
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 940,000 2023-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026280
us-gaap ConvertiblePreferredDividendsNetOfTax Convertible Preferred Dividends, Net of Tax USD 4.55M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001213900-22-072200
us-gaap CostOfRevenue Cost of Revenue USD 2.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-11 0001010549-17-000167
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD -178,408 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-30 0001213900-20-008020
us-gaap CustomerAdvancesAndDeposits Customer Advances and Deposits USD 8.45M 2015-06-30 2015 Q2 10-Q 2015-12-28 0001010549-15-000420
us-gaap CustomerAdvancesCurrent Customer Advances, Current USD 1.94M 2020-03-31 2020 Q1 10-Q 2020-05-14 0001213900-20-012258
us-gaap CustomersLiabilityForAcceptancesNet Customer's Liability for Acceptances, Net USD 80,406 2023-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-066936
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 0.285 2023-06-23 2023 Q2 10-Q 2023-08-14 0001213900-23-066936
us-gaap DebtInstrumentConvertibleNumberOfEquityInstruments Debt Instrument, Convertible, Number of Equity Instruments pure 350,000 2022-04-19 2023 Q2 10-Q 2023-08-14 0001213900-23-066936
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount CNY 15.00M 2021-12-31 2022 FY 10-K 2023-03-30 0001213900-23-024710
us-gaap DebtInstrumentFeeAmount Debt Instrument, Fee Amount USD 65,639 2023-04-13 2024 Q3 10-Q 2024-11-13 0001213900-24-097461
us-gaap DebtInstrumentInterestRateEffectivePercentage Debt Instrument, Interest Rate, Effective Percentage pure 0.039 2023-03-31 2023 Q2 10-Q 2023-08-14 0001213900-23-066936
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.033 2025-12-31 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap DebtInstrumentPeriodicPayment Debt Instrument, Periodic Payment USD 2.00M 2013-06-01 2013-06-21 2020 Q3 10-Q 2020-11-13 0001213900-20-036919
us-gaap DebtInstrumentRedemptionPricePercentage Debt Instrument, Redemption Price, Percentage pure 0.82 2024-12-09 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed pure 0.82 2023-01-01 2023-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097461
us-gaap DebtInstrumentRepurchaseAmount Debt Instrument, Repurchase Amount USD 100,000 2024-09-11 2024 Q3 10-Q 2024-11-13 0001213900-24-097461
us-gaap DebtWeightedAverageInterestRate Debt, Weighted Average Interest Rate pure 0.82 2023-06-23 2023 Q2 10-Q 2023-08-14 0001213900-23-066936
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 77,042 2014-01-01 2014-12-31 2014 FY 10-K 2015-12-28 0001010549-15-000416
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 30,334 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-11 0001010549-17-000167
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 0 2015-12-31 2015 FY 10-K 2016-03-30 0001010549-16-000541
us-gaap DeferredIncomeTaxesAndTaxCredits Deferred Income Taxes and Tax Credits USD 111,910 2018-01-01 2018-09-30 2019 Q3 10-Q 2019-11-14 0001213900-19-023467
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 68,419 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-30 0001213900-20-008020
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 780,415 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap DeferredRentCreditCurrent Deferred Rent Credit, Current USD -16,581 2014-03-31 2014 Q1 10-Q 2014-05-15 0001010549-14-000242
us-gaap DeferredRevenue Deferred Revenue USD 172,357 2016-09-30 2016 Q3 10-Q 2016-11-14 0001010549-16-000787
us-gaap DeferredRevenueAdditions Deferred Revenue, Additions USD 2.51M 2014-01-01 2014-12-31 2014 FY 10-K 2015-12-28 0001010549-15-000416
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 21.21M 2025-12-31 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap DeferredTaxAssetsGrossNoncurrent Deferred Tax Assets, Gross, Noncurrent USD 274,157 2011-09-30 2011 Q3 10-Q 2011-11-10 0001010549-11-001255
us-gaap DeferredTaxAssetsInventory Deferred Tax Assets, Inventory USD 286,310 2025-12-31 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 6.45M 2014-09-30 2014 Q3 10-Q 2014-11-14 0001010549-14-000619
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 23.20M 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap DeferredTaxAssetsNetCurrent Deferred Tax Assets, Net of Valuation Allowance, Current USD 0 2013-12-31 2013 FY 10-K 2014-03-20 0001010549-14-000114
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 2.08M 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028731
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 2.46M 2025-12-31 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign USD 7.68M 2025-12-31 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 337 2025-12-31 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 5.28M 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028731
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 3,201 2025-12-31 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap DeferredTaxAssetsTaxDeferredExpenseOther Deferred Tax Assets, Tax Deferred Expense, Other USD 1.08M 2025-12-31 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts USD 3,256 2025-12-31 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Impairment Losses USD 9.69M 2025-12-31 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other USD 8,038 2025-12-31 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Provision for Loan Losses USD 6,754 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028731
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 21.21M 2025-12-31 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 791,067 2018-03-31 2018 Q1 10-Q 2018-05-14 0001213900-18-006100
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets Deferred Tax Liabilities, Intangible Assets USD 747,805 2025-12-31 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap DeferredTaxLiabilitiesNoncurrent Deferred Tax Liabilities, Net, Noncurrent USD 741,863 2020-03-31 2020 Q1 10-Q 2020-05-14 0001213900-20-012258
us-gaap DefinedBenefitPlanAccumulatedBenefitObligation Defined Benefit Plan, Accumulated Benefit Obligation USD 244,153 2017-12-31 2017 FY 10-K 2018-04-02 0001213900-18-003895
us-gaap DepositsPaidForSecuritiesBorrowedAtCarryingValue Deposits Paid for Securities Borrowed, at Carrying Value USD 260,000 2025-12-31 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap Depreciation Depreciation USD 468,678 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 3.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 1.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 934,260 2010-12-31 2011 FY 10-K 2012-03-14 0001010549-12-000255
us-gaap DividendsStock Dividends, Stock USD 1.65M 2023-12-15 2023 FY 10-K 2024-04-01 0001213900-24-028731
us-gaap DueFromOtherRelatedParties Due from Other Related Parties USD 822,062 2020-09-30 2020 Q3 10-Q 2020-11-13 0001213900-20-036919
us-gaap DueFromRelatedParties Due from Related Parties USD 1.12M 2022-12-31 2022 FY 10-K 2023-03-30 0001213900-23-024710
us-gaap DueToOtherRelatedPartiesClassifiedCurrent Due to Other Related Parties, Current USD 1.35M 2022-12-31 2022 FY 10-K 2023-03-30 0001213900-23-024710
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 2.18M 2020-09-30 2020 Q3 10-Q 2020-11-13 0001213900-20-036919
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.12 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.07 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016151
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.12 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.25 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001213900-23-086100
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.25 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 0.25 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-109203
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD -8,439 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016151
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -941 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD -2,606 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-109203
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 0 2026-03-31 2026 Q1 10-Q 2026-05-15 0001213900-26-057705
us-gaap EmployeeStockOwnershipPlanESOPCompensationExpense Employee Stock Ownership Plan (ESOP), Compensation Expense USD 42,000 2022-10-03 2023 FY 10-K 2024-04-01 0001213900-24-028731
us-gaap EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage pure 1 2017-06-30 2017 Q2 10-Q 2017-08-14 0001213900-17-008653
us-gaap ExcessStockSharesIssued Excess Stock, Shares Issued shares 35,200 2021-09-09 2023 FY 10-K 2024-04-01 0001213900-24-028731
us-gaap FairValueNetAssetLiability Fair Value, Net Asset (Liability) USD 65,915 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028731
us-gaap FairValueOptionChangesInFairValueGainLoss1 Fair Value, Option, Changes in Fair Value, Gain (Loss) USD 15,243 2021-09-01 2021-09-09 2022 FY 10-K 2023-03-30 0001213900-23-024710
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 61,958 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.82 2023-09-12 2023 Q3 10-Q 2023-11-13 0001213900-23-086100
us-gaap FinancingInterestExpense Financing Interest Expense USD 3,584 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap FinancingReceivableModificationToTotalFinancingReceivablesExcludingAccruedInterestPercent FinancingReceivableModificationToTotalFinancingReceivablesExcludingAccruedInterestPercent pure 0.02 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-066936
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 9.30M 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap FinitelivedIntangibleAssetsAcquired1 Finite-lived Intangible Assets Acquired USD 6.13M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-30 0001213900-20-008020
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 11.85M 2025-12-31 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months USD 269,077 2015-12-31 2015 FY 10-K 2016-03-30 0001010549-16-000541
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 2.38M 2025-12-31 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive Finite-Lived Intangible Assets, Amortization Expense, Rolling after Year Five USD 183,105 2015-12-31 2015 FY 10-K 2016-03-30 0001010549-16-000541
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Five USD 35,412 2016-12-31 2016 FY 10-K 2017-03-31 0001010549-17-000112
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Four USD 61,288 2015-12-31 2015 FY 10-K 2016-03-30 0001010549-16-000541
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Three USD 117,541 2015-12-31 2015 FY 10-K 2016-03-30 0001010549-16-000541
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Two USD 160,947 2016-12-31 2016 FY 10-K 2017-03-31 0001010549-17-000112
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 2.38M 2025-12-31 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 2.38M 2025-12-31 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 2.38M 2025-12-31 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 2.38M 2025-12-31 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 46.75M 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 359,908 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD 137,638 2024-07-01 2024-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097461
us-gaap FurnitureAndFixturesGross Furniture and Fixtures, Gross USD 233,649 2013-09-30 2013 Q3 10-Q 2013-11-14 0001010549-13-000676
us-gaap GainLossOnSaleOfDerivatives Gain (Loss) on Sale of Derivatives USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-14 0001010549-13-000144
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -2,020 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 3.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap GoodwillAndIntangibleAssetImpairment Goodwill and Intangible Asset Impairment USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-20 0001010549-14-000114
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 17.02M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-26 0001213900-21-017981
us-gaap GovernmentContractReceivable Government Contract Receivable USD 340,000 2017-12-31 2017 FY 10-K 2018-04-02 0001213900-18-003895
us-gaap GrossProfit Gross Profit USD 461,027 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill) USD 496,808 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 496,808 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap IncomeLossBeforeCumulativeEffectOfChangeInAccountingPrinciple Income (Loss) before Cumulative Effect of Change in Accounting Principle (Deprecated 2011-01-31) USD 22.71M 2011-01-01 2011-12-31 2011 FY 10-K 2012-03-14 0001010549-12-000255
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD -6.23M 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-12-28 0001010549-15-000420
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -4.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD 17.82M 2011-01-01 2011-09-30 2011 Q3 10-Q/A 2012-03-06 0001010549-12-000234
us-gaap IncomeLossFromContinuingOperationsPerBasicShare Income (Loss) from Continuing Operations, Per Basic Share USD/shares -0.13 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-14 0001010549-16-000787
us-gaap IncomeLossFromContinuingOperationsPerDilutedShare Income (Loss) from Continuing Operations, Per Diluted Share USD/shares -0.13 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-14 0001010549-16-000787
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-12-28 0001010549-15-000422
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD -109,989 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-30 0001213900-20-008020
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 795,771 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 1,119 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary Effective Income Tax Rate Reconciliation, Equity in Earnings (Losses) of Unconsolidated Subsidiary, Amount USD 23.30M 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001213900-17-012067
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD -8.09M 2016-01-01 2016-12-31 2017 FY 10-K 2018-04-02 0001213900-18-003895
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -796,890 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap IncomeTaxReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount USD -178,408 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-30 0001213900-20-008020
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 1.40M 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-14 0001010549-13-000144
us-gaap IncomeTaxReconciliationTaxHolidays Effective Income Tax Rate Reconciliation, Tax Holiday, Amount USD 837,089 2016-01-01 2016-12-31 2017 FY 10-K 2018-04-02 0001213900-18-003895
us-gaap IncreaseDecreaseInAccountsAndOtherReceivables Increase (Decrease) in Accounts and Other Receivables USD 259,767 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 714,380 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-14 0001010549-14-000422
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -124,072 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-14 0001010549-14-000422
us-gaap IncreaseDecreaseInAccountsPayableTrade Increase (Decrease) in Accounts Payable, Trade USD -614,642 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 13.88M 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 465,753 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap IncreaseDecreaseInAccruedTaxesPayable Increase (Decrease) in Accrued Taxes Payable USD 123,921 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-13 0001213900-20-036919
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -67,004 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap IncreaseDecreaseInCustomerAdvances Increase (Decrease) in Customer Advances USD 1.47M 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-14 0001213900-20-012258
us-gaap IncreaseDecreaseInDeferredIncomeTaxes Increase (Decrease) in Deferred Income Taxes USD 67,789 2011-01-01 2011-09-30 2011 Q3 10-Q/A 2012-03-06 0001010549-12-000234
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -1.74M 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001010549-16-000541
us-gaap IncreaseDecreaseInDepositOtherAssets Increase (Decrease) in Deposit Assets USD -17,509 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-11 0001010549-17-000167
us-gaap IncreaseDecreaseInIncomeTaxes Increase (Decrease) in Income Taxes USD 30,334 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-11 0001010549-17-000167
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD -537,154 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap IncreaseDecreaseInInventoryForLongTermContractsOrPrograms Increase (Decrease) in Inventory for Long-term Contracts or Programs USD 231,326 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-12-28 0001010549-15-000420
us-gaap IncreaseDecreaseInOtherAccountsPayable Increase (Decrease) in Other Accounts Payable USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-20 0001010549-14-000114
us-gaap IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities USD -142,555 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap IncreaseDecreaseInOtherReceivables Increase (Decrease) in Other Receivables USD -342,012 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-14 0001010549-14-000619
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -1.47M 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-14 0001010549-14-000619
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 44,936 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-066936
us-gaap IncreaseDecreaseInPrepaidExpensesOther Increase (Decrease) in Prepaid Expenses, Other USD 11,653 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap IncreaseDecreaseInPrepaidSupplies Increase (Decrease) in Prepaid Supplies USD 14,078 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-090173
us-gaap IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease Indefinite-lived Intangible Assets, Period Increase (Decrease) USD 0 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-12-28 0001010549-15-000422
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 37.30M 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap IntangibleAssetsNetIncludingGoodwill Intangible Assets, Net (Including Goodwill) USD 37.30M 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap InterestAndDebtExpense Interest and Debt Expense USD 250,314 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0001213900-23-024710
us-gaap InterestExpense Interest Expense USD 28,804 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap InterestExpenseCustomerDeposits Interest Expense, Customer Deposits USD 105,545 2023-04-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-066936
us-gaap InterestExpenseDebt Interest Expense, Debt USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-090173
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 79,506 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap InterestExpenseOther Interest Expense, Other USD 19,844 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap InterestExpenseRelatedParty Interest Expense, Related Party USD 13,546 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0001213900-23-024710
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 6,773 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-066936
us-gaap InterestIncomeOther Interest Income, Other USD 2,003 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 410,509 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001213900-17-012067
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 47,090 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap InventoryAdjustments Inventory Adjustments USD 1.30M 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 1.45M 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap InventoryGross Inventory, Gross USD 2.62M 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap InventoryNet Inventory, Net USD 1.32M 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 869,278 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap InventoryValuationReserves Inventory Valuation Reserves USD 6.20M 2017-09-30 2017 Q3 10-Q 2017-11-14 0001213900-17-012067
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 304,884 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap InventoryWriteDown Inventory Write-down USD 105,987 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 2,390 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap InvestmentInterestRateFloor InvestmentInterestRateFloor pure 0.043 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028731
us-gaap LandAndLandImprovements Land and Land Improvements USD 389,808 2023-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-066936
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 135,418 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 77,382 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 1,426 2019-06-30 2019 Q2 10-Q 2019-08-14 0001213900-19-015792
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 38,072 2025-12-31 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 58,036 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 76,144 2025-12-31 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 3,654 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap LessorOperatingLeasePaymentsToBeReceived Lessor, Operating Lease, Payments to be Received USD 158,100 2023-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-066936
us-gaap LessorOperatingLeasePaymentsToBeReceivedThreeYears Lessor, Operating Lease, Payment to be Received, Year Three USD 66,056 2021-09-30 2021 Q3 10-Q 2021-11-12 0001213900-21-058670
us-gaap LessorOperatingLeasePaymentsToBeReceivedTwoYears Lessor, Operating Lease, Payment to be Received, Year Two USD 88,075 2021-09-30 2021 Q3 10-Q 2021-11-12 0001213900-21-058670
us-gaap Liabilities Liabilities USD 7.86M 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 46.93M 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap LiabilitiesCurrent Liabilities, Current USD 7.03M 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap LineOfCredit Long-term Line of Credit CNY 3.80M 2023-12-20 2023 FY 10-K 2024-04-01 0001213900-24-028731
us-gaap LineOfCreditFacilityInterestRateDuringPeriod Line of Credit Facility, Interest Rate During Period pure 0.029 2025-09-21 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 4.50M 2016-04-30 2021 FY 10-K 2022-03-30 0001213900-22-016151
us-gaap LinesOfCreditCurrent Line of Credit, Current USD 2.23M 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap LongTermConstructionLoanCurrent Long-term Construction Loan, Current USD 3.80M 2022-12-31 2022 FY 10-K 2023-03-30 0001213900-23-024710
us-gaap LongtermConstructionLoanCurrentAndNoncurrent Long-term Construction Loan USD 674,405 2019-07-08 2019 Q3 10-Q 2019-11-14 0001213900-19-023467
us-gaap LongTermDebt Long-term Debt USD 4.33M 2021-09-30 2021 Q3 10-Q 2021-11-12 0001213900-21-058670
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 4.69M 2021-06-30 2021 Q2 10-Q 2021-08-13 0001213900-21-042474
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 2.21M 2017-06-30 2017 Q2 10-Q 2017-08-14 0001213900-17-008653
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 2.18M 2018-09-30 2018 Q3 10-Q 2018-11-14 0001213900-18-015783
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 2.12M 2019-09-30 2019 Q3 10-Q 2019-11-14 0001213900-19-023467
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 4.33M 2021-09-30 2021 Q3 10-Q 2021-11-12 0001213900-21-058670
us-gaap LongTermDebtPercentageBearingFixedInterestRate Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate pure 0.036 2026-06-20 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap LongtermDebtWeightedAverageInterestRate Long-term Debt, Weighted Average Interest Rate, at Point in Time pure 0.85 2022-08-03 2022 Q3 10-Q 2022-11-14 0001213900-22-072200
us-gaap LongTermLineOfCredit Long-term Line of Credit, Noncurrent USD 1.39M 2024-12-31 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap LossFromCatastrophes Loss from Catastrophes USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001010549-16-000541
us-gaap MachineryAndEquipmentGross Machinery and Equipment, Gross USD 26.76M 2023-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-066936
us-gaap ManagementAndServiceFeesRate ManagementAndServiceFeesRate pure 0.15 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001213900-23-086100
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD 39,432 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-15 0001010549-14-000242
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 4.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD -1.47M 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001213900-17-012067
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -10,880 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -67,324 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001213900-17-012067
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -1.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD 70,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -4.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -77,116 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap NotesAndLoansPayable Notes and Loans Payable USD 0 2020-12-31 2020 FY 10-K 2021-03-26 0001213900-21-017981
us-gaap NotesPayable Notes Payable USD 1.18M 2021-09-09 2022 FY 10-K 2023-03-30 0001213900-23-024710
us-gaap NotesPayableCurrent Notes Payable, Current USD 0 2016-12-31 2016 FY 10-K 2017-03-31 0001010549-17-000112
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 951,506 2022-12-31 2022 FY 10-K 2023-03-30 0001213900-23-024710
us-gaap NotesPayableRelatedPartiesNoncurrent Notes Payable, Related Parties, Noncurrent USD 372,578 2022-12-31 2022 FY 10-K 2023-03-30 0001213900-23-024710
us-gaap OperatingExpenses Operating Expenses USD 4.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -4.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap OperatingLeaseCost Operating Lease, Cost USD 17,986 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-15 0001213900-26-057705
us-gaap OperatingLeaseLeaseIncome Operating Lease, Lease Income USD 75,154 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-12 0001213900-21-058670
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 131,764 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 74,447 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 57,317 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap OperatingLeasePayments Operating Lease, Payments USD 18,830 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-15 0001213900-26-057705
us-gaap OperatingLeasePaymentsUse Operating Lease, Payments, Use USD 117,637 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028731
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 129,348 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 59,365 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 178,357 2021-06-30 2021 Q2 10-Q 2021-08-13 0001213900-21-042474
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 95,986 2019-12-31 2019 FY 10-K 2020-03-30 0001213900-20-008020
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 88,420 2021-06-30 2021 Q2 10-Q 2021-08-13 0001213900-21-042474
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 89,937 2021-06-30 2021 Q2 10-Q 2021-08-13 0001213900-21-042474
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.03 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 4.30M 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap OperatingLossCarryforwardsValuationAllowance Operating Loss Carryforwards, Valuation Allowance USD 5.10M 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028731
us-gaap OptionIndexedToIssuersEquityIndexedShares Option Indexed to Issuer's Equity, Indexed Shares shares 13,300 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028731
us-gaap OtherCashEquivalentsAtCarryingValue Other Cash Equivalents, at Carrying Value USD 700,000 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-068984
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax (Deprecated 2012-01-31) USD 3.04M 2013-01-01 2013-06-30 2013 Q2 10-Q 2013-08-14 0001010549-13-000521
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax USD 675 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 1.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax USD 408,746 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -2.05M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-14 0001213900-18-010992
us-gaap OtherComprehensiveIncomeLossTax Other Comprehensive Income (Loss), Tax USD -6.10M 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-12-28 0001010549-15-000420
us-gaap OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent Other Deferred Compensation Arrangements, Liability, Classified, Noncurrent USD 375,351 2023-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-066936
us-gaap OtherDeferredCompensationArrangementsLiabilityCurrent Other Deferred Compensation Arrangements, Liability, Current USD 959,506 2023-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-066936
us-gaap OtherEmployeeRelatedLiabilitiesCurrent Other Employee-related Liabilities, Current USD 1.94M 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap OtherExpenses Other Expenses USD 126,808 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-14 0001213900-18-006100
us-gaap OtherLiabilities Other Liabilities USD 2.24M 2023-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-066936
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 2.45M 2023-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-066936
us-gaap OtherLoansPayable Other Loans Payable CNY 30.00M 2016-04-30 2017 Q2 10-Q 2017-08-14 0001213900-17-008653
us-gaap OtherNotesPayable Other Notes Payable USD 959,506 2023-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-066936
us-gaap OtherNotesPayableCurrent Other Notes Payable, Current USD 8.18M 2023-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-066936
us-gaap OtherOperatingActivitiesCashFlowStatement Other Operating Activities, Cash Flow Statement USD 95,985 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-30 0001213900-20-008020
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 84,244 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap OtherRestrictedAssetsCurrent Other Restricted Assets, Current USD 14,513 2017-03-31 2017 Q1 10-Q 2017-05-11 0001010549-17-000167
us-gaap OtherTaxExpenseBenefit Other Tax Expense (Benefit) USD 178,408 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-28 0001213900-19-005094
us-gaap PaymentsForAdvanceToAffiliate Payments for Advance to Affiliate CNY 3.80M 2024-11-11 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap PaymentsForConstructionInProcess Payments for Construction in Process USD -310,247 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-12-28 0001010549-15-000422
us-gaap PaymentsForFees Payments for Other Fees USD 10,934 2024-05-23 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap PaymentsForLoans Payments for Loans USD 738,379 2019-07-08 2025 Q3 10-Q 2025-11-12 0001213900-25-109203
us-gaap PaymentsForMortgageDeposits Payments for Mortgage Deposits CNY 856,660 2020-10-31 2023 FY 10-K 2024-04-01 0001213900-24-028731
us-gaap PaymentsForProceedsFromProductiveAssets Payments for (Proceeds from) Productive Assets USD 18,866 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097461
us-gaap PaymentsOfDividendsPreferredStockAndPreferenceStock Payments of Ordinary Dividends, Preferred Stock and Preference Stock USD -38,145 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-15 0001010549-14-000242
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 72,614 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD -5.40M 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-15 0001010549-14-000242
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 10,880 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap PreconfirmationAccumulatedOtherComprehensiveIncomeLoss Preconfirmation, Accumulated Other Comprehensive Income (Loss) USD 15.63M 2018-03-31 2018 Q1 10-Q 2018-05-14 0001213900-18-006100
us-gaap PreferredStockConvertibleSharesIssuable PreferredStockConvertibleSharesIssuable shares 1.52M 2022-09-30 2022 Q3 10-Q 2022-11-14 0001213900-22-072200
us-gaap PreferredStockNoParValue Preferred Stock, No Par Value USD/shares 0.001 2014-09-30 2014 Q3 10-Q 2014-11-14 0001010549-14-000619
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap PreferredStockRedemptionAmount Preferred Stock, Redemption Amount USD 200,000 2022-08-03 2022 Q3 10-Q 2022-11-14 0001213900-22-072200
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2017-03-31 2017 Q1 10-Q 2017-05-11 0001010549-17-000167
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2017-03-31 2017 Q1 10-Q 2017-05-11 0001010549-17-000167
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2017-03-31 2017 Q1 10-Q 2017-05-11 0001010549-17-000167
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 88,401 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap PrepaidExpenseCurrentAndNoncurrent Prepaid Expense USD 404,370 2014-12-31 2014 FY 10-K 2015-12-28 0001010549-15-000416
us-gaap PrepaymentFeesOnAdvancesNet Prepayment Fees on Advances, Net USD -714,697 2014-01-01 2014-12-31 2014 FY 10-K 2015-12-28 0001010549-15-000416
us-gaap ProceedsFromConstructionLoansPayable Proceeds from Construction Loans Payable USD -145,176 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-11 0001010549-17-000167
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 4.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 5.00M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-30 0001213900-23-024710
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 1.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap ProceedsFromLoans Proceeds from Loans USD 604,756 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-14 0001010549-14-000619
us-gaap ProceedsFromLongTermLinesOfCredit Proceeds from Long-term Lines of Credit CNY 10.00M 2026-09-17 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-20 0001010549-14-000114
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 218,489 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap ProceedsFromRepaymentsOfLinesOfCredit Proceeds from (Repayments of) Lines of Credit USD 505,114 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-066936
us-gaap ProceedsFromRepaymentsOfRelatedPartyDebt Proceeds from (Repayments of) Related Party Debt USD -77,530 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-13 0001213900-20-036919
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 5.21M 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-15 0001010549-14-000242
us-gaap ProceedsFromShortTermDebt Proceeds from Short-term Debt USD -4.52M 2016-01-01 2016-12-31 2017 FY 10-K 2018-04-02 0001213900-18-003895
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 2.58M 2010-01-01 2010-12-31 2011 FY 10-K 2012-03-14 0001010549-12-000255
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -593,029 2023-04-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-066936
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 39.49M 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 4.12M 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap PropertyPlantAndEquipmentOther Property, Plant and Equipment, Other, Gross USD 3.15M 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap PropertyPlantAndEquipmentOtherNet Property, Plant and Equipment, Other, Net USD 7.10M 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028731
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 12,270 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap ProvisionForOtherCreditLosses Provision for Other Credit Losses USD 6,128 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap ProvisionForOtherLosses Provision for Other Losses USD -13.70M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap ReceivablesNetCurrent Receivables, Net, Current USD 91,753 2023-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-066936
us-gaap ReceivableWithImputedInterestNetAmount Receivable with Imputed Interest, Net Amount USD 5,699 2023-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-066936
us-gaap RelatedPartyTransactionAmountsOfTransaction Related Party Transaction, Amounts of Transaction USD 1.10M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-066936
us-gaap RepaymentsOfConstructionLoansPayable Repayments of Construction Loans Payable USD 2.33M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-30 0001213900-23-024710
us-gaap RepaymentsOfLinesOfCredit Repayments of Lines of Credit USD 1.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap RepaymentsOfLongTermLinesOfCredit Repayments of Long-term Lines of Credit CNY 1.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD -3.84M 2010-01-01 2010-12-31 2011 FY 10-K 2012-03-14 0001010549-12-000255
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 154,114 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap RepaymentsOfShortTermDebt Repayments of Short-term Debt CNY 551,250 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-090173
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 119,266 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap RestrictedCash Restricted Cash USD 222,996 2020-06-30 2021 Q2 10-Q 2021-08-13 0001213900-21-042474
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 957,653 2020-12-31 2020 FY 10-K 2021-03-26 0001213900-21-017981
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 900,000 2023-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-066936
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 331,038 2020-03-31 2021 Q1 10-Q 2021-05-14 0001213900-21-026413
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -51.72M 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap RetainedEarningsAppropriated Retained Earnings, Appropriated USD -41.70M 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-068984
us-gaap RevenueFromGrants Revenue from Grants (Deprecated 2018-01-31) USD 348,672 2016-01-01 2016-06-30 2017 Q2 10-Q 2017-08-14 0001213900-17-008653
us-gaap Revenues Revenues USD 3.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 214,070 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap SaleOfStockConsiderationReceivedPerTransaction Sale of Stock, Consideration Received Per Transaction USD 5.00M 2021-11-01 2021-11-17 2022 FY 10-K 2023-03-30 0001213900-23-024710
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 6,267 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028731
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 0.55 2023-12-15 2023 FY 10-K 2024-04-01 0001213900-24-028731
us-gaap SellingExpense Selling Expense USD 343,644 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-090173
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.184 2021-09-01 2021-09-09 2022 FY 10-K 2023-03-30 0001213900-23-024710
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.038 2022-10-04 2022 FY 10-K 2023-03-30 0001213900-23-024710
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate pure 1.155 2022-10-04 2022 FY 10-K 2023-03-30 0001213900-23-024710
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 559,800 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-090173
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 82 2023-06-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-066936
us-gaap ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Volatility Rate pure 1.155 2022-10-04 2023 FY 10-K 2024-04-01 0001213900-24-028731
us-gaap ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate Share-based Goods and Nonemployee Services Transaction, Valuation Method, Risk Free Interest Rate pure 0.038 2022-10-04 2023 FY 10-K 2024-04-01 0001213900-24-028731
us-gaap SharePrice Share Price USD/shares 2 2026-07-22 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap SharesIssued Shares, Issued shares 6,425 2022-03-23 2023 FY 10-K 2024-04-01 0001213900-24-028731
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 0.455 2024-09-30 2024 Q3 10-Q 2024-11-13 0001213900-24-097461
us-gaap ShortTermBankLoansAndNotesPayable Short-term Bank Loans and Notes Payable CNY 3.00M 2021-07-12 2021 FY 10-K 2022-03-30 0001213900-22-016151
us-gaap ShortTermBorrowings Short-term Debt USD 1.57M 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap ShortTermDebtPercentageBearingFixedInterestRate Short-term Debt, Percentage Bearing Fixed Interest Rate pure 0.033 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired Statutory Accounting Practices, Statutory Capital and Surplus Required USD 8.14M 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap StatutoryAccountingPracticesStatutoryNetIncomeAmount Statutory Accounting Practices, Statutory Net Income Amount USD 8.14M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-066936
us-gaap StockGrantedDuringPeriodValueSharebasedCompensationForfeited Shares Granted, Value, Share-based Payment Arrangement, Forfeited USD 36,270 2022-10-04 2023 FY 10-K 2024-04-01 0001213900-24-028731
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 39.07M 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap StockholdersEquityNoteSubscriptionsReceivable Stockholders' Equity Note, Subscriptions Receivable USD 180,000 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap StockIssued1 Stock Issued USD 14.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 78,333 2023-06-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-066936
us-gaap StockIssuedDuringPeriodSharesConversionOfUnits Stock Issued During Period, Shares, Conversion of Units shares 126,667 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0001213900-23-024710
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 81,576 2024-12-09 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 1.65M 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028731
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 1.47M 2024-01-01 2024-12-31 2025 FY 10-K 2026-04-01 0001213900-26-038521
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 1.85M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026280
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 800,000 2023-04-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001213900-23-066936
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 4.38M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 42,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028731
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 36,270 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0001213900-23-024710
us-gaap StockOptionExercisePriceIncrease Stock Option, Exercise Price, Increase USD/shares 28 2022-10-04 2023 FY 10-K 2024-04-01 0001213900-24-028731
us-gaap StockOptionPlanExpense Stock or Unit Option Plan Expense USD 78,270 2022-01-01 2022-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028731
us-gaap StockRepurchasedDuringPeriodShares Stock Repurchased During Period, Shares shares 2.50M 2026-07-22 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap Supplies Prepaid Supplies USD 1.05M 2020-03-31 2020 Q1 10-Q 2020-05-14 0001213900-20-012258
us-gaap TaxBenefitFromStockOptionsExercised Tax Benefit from Stock Options Exercised (Deprecated 2012-01-31) USD 5.86M 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-14 0001010549-12-001213
us-gaap TaxCreditCarryforwardAmount Tax Credit Carryforward, Amount USD 7.00M 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 326,951 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap TradeReceivablesHeldForSaleNet Disposal Group, Including Discontinued Operation, Trade Receivables (Deprecated 2015-01-31) USD 52.52M 2013-09-30 2013 Q3 10-Q 2013-11-14 0001010549-13-000676
us-gaap UndistributedEarnings Undistributed Earnings, Basic USD 26.30M 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001213900-17-012067
us-gaap UnrecognizedTaxBenefitsResultingInNetOperatingLossCarryforward Unrecognized Tax Benefits Resulting in Net Operating Loss Carryforward (Deprecated 2014-01-31) USD 3.35M 2013-06-30 2013 Q2 10-Q 2013-08-14 0001010549-13-000521
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 2.41M 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001010549-16-000541
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 36.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 46.13M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0001213900-22-016151
us-gaap WeightedAverageNumberOfSharesIssuedBasic Weighted Average Number of Shares Issued, Basic shares 43.58M 2013-01-01 2013-06-30 2013 Q2 10-Q 2013-08-14 0001010549-13-000521
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 36.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-18 0001213900-26-121812

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →